Showing results (461-470 of 490) with videos related to

Sort By:
Pageof 49
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 17, 2016
T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft DysfunctionM Pain, P-J Royer, J Loy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2020
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensusG Curigliano, S Banerjee, A Cervantes, et al.
Lung Cancer (Amsterdam, Netherlands)|January 8, 2004
Induction treatment before surgery for non-small cell lung cancerW E Eberhardt, K S Albain, H Pass, et al.
The European Respiratory Journal|July 23, 2011
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinomaN Girard, C S Sima, D M Jackman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2015
High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targetsV Fallet, R Saffroy, N Girard, et al.
Nano Letters|October 18, 2012
Morphology control of nanostructures: Na-doped PbTe-PbS systemJiaqing He, I D Blum, Hui-Qiong Wang, et al.
Respiratory Medicine and Research|June 22, 2020
Proposals for managing patients with thoracic malignancies during COVID-19 pandemicN Girard, L Greillier, G Zalcman, et al.
Public Health Genomics|April 17, 2010
Framing genomics, public health research and policy: points to considerBartha Maria Knoppers, T Leroux, H Doucet, et al.
Nature Communications|April 16, 2015
Twisting phonons in complex crystals with quasi-one-dimensional substructuresXi Chen, Annie Weathers, Jesús Carrete, et al.
ESMO Open|June 7, 2023
Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trialN Girard, S Ponce Aix, S Cedres, et al.
Pageof 49